Prolight’s CEO to BioStock: ”Proof-of-Performance in whole blood important milestone”
Prolight Diagnostics has demonstrated Proof-of-Performance in whole blood for its digital test system Psyros. It is already known that the system performs as promised for measuring troponin in serum, as well as thyroid-stimulating hormone in blood plasma. The latest results show that the system has equivalent performance in whole blood. BioStock reached out to the company's CEO Ulf Bladin to find out more.
Read the full article at biostock.se:
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se